Effects of the selective AMPA modulator NBI‐1065845 on the pharmacokinetics of midazolam or ethinyl estradiol–levonorgestrel in healthy adults

Documenti analoghi

• Investigation of pharmacokinetic drug interaction between clesacostat and DGAT2 inhibitor ervogastat in healthy adult participants
  di: Aarti Sawant‐Basak, et al.
  Pubblicazione: (2024)
• Effects of multiple‐dose administration of zavegepant nasal spray on the single‐dose pharmacokinetics of ethinyl estradiol‐levonorgestrel
  di: Rajinder Bhardwaj, et al.
  Pubblicazione: (2024)
• A phase I, randomized, placebo‐controlled trial to evaluate the pharmacokinetics, safety, and tolerability of nirsevimab in healthy Chinese adults
  di: Xiaomeng Mao, et al.
  Pubblicazione: (2024)
• Population pharmacokinetics of iruplinalkib in healthy volunteers and patients with solid tumors
  di: Guihong Yang, et al.
  Pubblicazione: (2024)
• Mass balance and pharmacokinetic characterization of zavegepant in healthy male subjects
  di: Rajinder Bhardwaj, et al.
  Pubblicazione: (2024)